Consent by Proxy: The Key to More Inclusive, More Reliable Trials

The inclusion of participants who lack the capacity for informed consent is essential for ensuring the generalizability of clinical trial outcomes, particularly in studies involving populations under the age of consent or those with cognitive impairments, critical illnesses, or developmental disorders. In such trials, obtaining informed consent from a Legally Authorized Representative (LAR) or proxy […]